Used in research settings to quantify levels of Serum Amyloid A (SAA) in human biological samples such as serum, plasma, or cell culture supernatants. This kit enables detection and measurement of SAA, an acute-phase protein, to study inflammatory responses, monitor disease progression, and evaluate the effectiveness of anti-inflammatory treatments. Commonly applied in studies related to chronic inflammatory diseases, cardiovascular conditions, infections, and autoimmune disorders. Provides a reliable and sensitive method for assessing SAA concentration, supporting biomarker validation and clinical research.